Results 1 to 10 of about 2,931,663 (352)

Zonulin-Assessed Intestinal Permeability and Body Composition Changes in Systemic Sclerosis. [PDF]

J Clin Med
Gigante A, Pellicano C, Iacovino ML, Gallicchio C, Oliva A, Rosato E, Muscaritoli M.   +6 more
europepmc   +1 more source

Editorial: Systemic sclerosis: immunological impacts. [PDF]

Front Immunol
Komura K, Matsushita T.
europepmc   +1 more source

Cognitive impairment, depression, and anxiety in systemic sclerosis. [PDF]

Front Med (Lausanne)
Szekanecz V, Lekli L, Bokor L, Kardos Z, Kardos VK, Hodosi K, Szamosi S, Szűcs G, Oláh C, Horváth Á, Molnár J, Szekanecz Z.   +11 more
europepmc   +1 more source

Anifrolumab-A Potential New Systemic Sclerosis Treatment. [PDF]

J Clin Med
Radić M, Prižmić PŠ, Bečić T, Đogaš H, Perković D, Radić J, Fabijanić D.   +6 more
europepmc   +1 more source

Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset. [PDF]

Semin Arthritis Rheum
Cameron S, Mohassel P, Shah AA, Wigley F, Hummers LK, Paik JJ.   +5 more
europepmc   +1 more source

Clinical advances and multifactorial pathophysiological mechanisms of neuropsychiatric comorbidity in systemic sclerosis. [PDF]

Front Immunol
Chen J, Guo R, Zhou X, Gao J, Xu K.
europepmc   +1 more source

An Engineered Glove for the Objective Assessment of Hand Dexterity in Patients With Systemic Sclerosis. [PDF]

ACR Open Rheumatol
Sulli A, Hysa E, Clini P, Gotelli E, Vojinovic T, Pizzorni C, Jaffal A, Paolino S, Campitiello R, Smith V, Cutolo M.   +10 more
europepmc   +1 more source

Understanding patient-reported disease burden in systemic sclerosis: key clinical and demographic features revealed by the EULAR Systemic Sclerosis Impact of Disease (ScleroID) Questionnaire. [PDF]

EULAR Rheumatol Open
Muraru S, Fligelstone K, Kennedy AT, Roennow A, Allanore Y, Carreira PE, Czirják L, Nagy G, Denton CP, Hesselstrand R, Sandqvist G, Kowal-Bielecka O, Bruni C, Matucci-Cerinic M, Mihai C, Gheorghiu AM, Müller-Ladner U, Kvien TK, Heiberg T, Distler O, Becker MO, Dobrota R.   +21 more
europepmc   +1 more source

Noncoding RNA TY1 reverses fibrosis in systemic sclerosis by attenuating the cGAS/STING pathway. [PDF]

JCI Insight
Jones XM, Soussi S, Ciullo A, Tsi K, Liu W, Li L, Fournier M, Mesquita T, Marchevsky AM, Bottini N, Boin F, Ibrahim AG, Marbán E.   +12 more
europepmc   +1 more source